GNTA Stock Summary and Trading Ideas (Genenta Science S.P.A. - American Depositary Shares | NASDAQ:GNTA)

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Genenta Science S.P.A. - American Depositary Shares trades on the NASDAQ stock market under the symbol GNTA.

As of April 28, 2026, GNTA stock price declined to $0.72 with 28,368 million shares trading.

GNTA has a beta of 2.05, meaning it tends to be more sensitive to market movements. GNTA has a correlation of 0.04 to the broad based SPY ETF.

GNTA has a market cap of $16.85 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, GNTA traded as high as $10.00 and as low as $.59.

GNTA has underperformed the market in the last year with a return of -82.2%, while the SPY ETF gained +30.6%. In the last 3 month period, GNTA fell short of the market, returning -53.3%, while SPY returned +2.6%. However, in the most recent 2 weeks GNTA has outperformed the stock market by returning +11.9%, while SPY returned +3.7%.

GNTA support price is $.69 and resistance is $.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNTA shares will trade within this expected range on the day.